ArticleJournal of the American Geriatrics Society2008
Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process.
Article in Journal of the American Geriatrics Society, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04288193 (Implementation of a Pharmacist-Driven Antipsychotic Deprescribing Initiative in the Program of All-inclusive Care for the Elderly), which is not on this map. Cited by 91 papers, 9 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Implementation of a Pharmacist-Driven Antipsychotic Deprescribing Initiative in the Program of All-inclusive Care for the Elderly (PACE) Setting: A Pilot Study
Who cites it
91 citing papers in PubMed, 9 syntheses or guidelines pooled it.
- Implementation of Electronic Informed Consent in Biomedical Research and Stakeholders' Perspectives: Systematic Review.Journal of medical Internet research · 2020Pooled it
- Generic instruments for drug discontinuation in primary care: A systematic review.British journal of clinical pharmacology · 2020Pooled it
- Does Deprescribing Improve Quality of Life? A Systematic Review of the Literature.Drugs & aging · 2019Pooled it
- Discontinuation of Preventive Medicines in Older People with Limited Life Expectancy: A Systematic Review.Drugs & aging · 2017Pooled it
- A systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practice.British journal of clinical pharmacology · 2015Pooled it
- Patient barriers to and enablers of deprescribing: a systematic review.Drugs & aging · 2013Pooled it
- Studies to reduce unnecessary medication use in frail older adults: a systematic review.Drugs & aging · 2013Pooled it
- Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity.Journal of the American Geriatrics Society · 2012Guideline
- Patient-centered care for older adults with multiple chronic conditions: a stepwise approach from the American Geriatrics Society: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity.Journal of the American Geriatrics Society · 2012Guideline
- Evaluating the Safety of an Educational Deprescribing Intervention: Lessons from the Optimize Trial.Drugs & aging · 2024Trial
- Trial
- Associations Between Polypharmacy, Symptom Burden, and Quality of Life in Patients with Advanced, Life-Limiting Illness.Journal of general internal medicine · 2019Trial
- Nursing home team-care deprescribing study: a stepped-wedge randomised controlled trial protocol.BMJ open · 2017Trial
- Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial.JAMA internal medicine · 2015 · on this mapTrial
- Discontinuing inappropriate medication in nursing home residents (DIM-NHR Study): protocol of a cluster randomised controlled trial.BMJ open · 2014Trial
- Article
- Reporting patterns of adverse drug withdrawal events using individual case safety reports in the FAERS and Eudravigilance databases.Exploratory research in clinical and social pharmacy · 2026Article
- The Reporting and Methodological Recommendations for Observational Studies Estimating the Effects of Deprescribing Medications (REMROSE-D) ISPE-Endorsed Guidance.Pharmacoepidemiology and drug safety · 2025Article
- Assessing causality in deprescribing studies: A focus on adverse drug events and adverse drug withdrawal events.Journal of the American Geriatrics Society · 2025Article
- The Health Costs of Cost Sharing.The quarterly journal of economics · 2024Article
31 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Thousands of Americans are injured or die each year from adverse drug reactions, many of which are preventable. The burden of harm conveyed by the use of medications is a significant public health problem, and therefore, improving the medication-use process is a priority. Recent and ongoing efforts to improve the medication-use process have focused primarily on improving medication prescribing, and not much emphasis has been put on improving medication discontinuation. A formalized approach for rationally discontinuing medications is a necessary antecedent to improving medication safety and improving the nation's quality of care. This article proposes a conceptual framework for revising the prescribing stage of the medication-use process to include discontinuing medications. This framework has substantial practice and research implications, especially for the clinical care of older persons, who are particularly susceptible to the adverse effects of medications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.